Baltimore early cancer detection startup raises $3 million

A Baltimore company has raised $3 million to support the launch of a new diagnostic tool that detects the warning signs of esophageal cancer. Previse, an early cancer detection company founded in 2019 under their previous name Capsulomics, will use the funding to expand the launch of Esopredict, which can detect esophageal cancer by analyzing changes in a patient's DNA. Maryland Technology Development Corp. (TEDCO), Wexford Science and Technology, Riptide Ventures, Gaingels and numerous angel investors …
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news